Position in TRLV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$939,177
New position
Shares Held
95,542
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,170,999 across 30 Drug Manufacturers - Specialty & Generic names. TRLV ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $939,177 | 95,542 | Shares | Defined | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||